Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
2729 | 3281 | 32.4 | 62% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
210 | 3 | IMMUNOLOGY//JOURNAL OF INTERFERON RESEARCH//NK CELLS | 51916 |
2729 | 2 | THYMOSIN BETA 4//THYMOSIN ALPHA 1//PROTHYMOSIN ALPHA | 3281 |
8289 | 1 | THYMOSIN ALPHA 1//PROTHYMOSIN ALPHA//THYMALFASIN | 1270 |
16320 | 1 | THYMOSIN BETA 4//THYMOSIN BETA4//BETA THYMOSIN | 660 |
16412 | 1 | THYMULIN//RAD FTS//THYMULIN GENE THERAPY | 655 |
17726 | 1 | BACTERIAL EXTRACT//CAS 121808 62 6//OM 85 BV | 585 |
34452 | 1 | AVIAMINE//LEVAMIN//LEVAMINE 70 | 111 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | THYMOSIN BETA 4 | authKW | 1445059 | 6% | 82% | 189 |
2 | THYMOSIN ALPHA 1 | authKW | 830623 | 4% | 74% | 121 |
3 | PROTHYMOSIN ALPHA | authKW | 787021 | 3% | 83% | 102 |
4 | THYMOSIN BETA4 | authKW | 449285 | 2% | 93% | 52 |
5 | THYMOSIN | authKW | 410307 | 2% | 70% | 63 |
6 | THYMULIN | authKW | 325109 | 2% | 56% | 62 |
7 | BETA THYMOSIN | authKW | 301108 | 1% | 83% | 39 |
8 | THYMOSIN BETA 10 | authKW | 232612 | 1% | 83% | 30 |
9 | BACTERIAL EXTRACT | authKW | 196556 | 1% | 81% | 26 |
10 | CAS 121808 62 6 | authKW | 169724 | 1% | 79% | 23 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Immunology | 11560 | 29% | 0% | 960 |
2 | Pharmacology & Pharmacy | 2361 | 18% | 0% | 581 |
3 | Biochemistry & Molecular Biology | 1269 | 20% | 0% | 660 |
4 | Cell Biology | 1115 | 11% | 0% | 370 |
5 | Medicine, Research & Experimental | 828 | 7% | 0% | 231 |
6 | Endocrinology & Metabolism | 683 | 7% | 0% | 222 |
7 | Oncology | 449 | 8% | 0% | 268 |
8 | Chemistry, Medicinal | 266 | 3% | 0% | 113 |
9 | Biophysics | 246 | 4% | 0% | 140 |
10 | Allergy | 237 | 1% | 0% | 48 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | PARASITOL GENET | 58079 | 0% | 39% | 16 |
2 | SECT GENES GENE PROD | 46524 | 0% | 100% | 5 |
3 | IMMUNOPEPTIDE CHEM | 22324 | 0% | 40% | 6 |
4 | INIBIOLP | 20342 | 1% | 13% | 17 |
5 | HEAD NECK OTORHINOLARYNGOL OPERAT UNIT | 18610 | 0% | 100% | 2 |
6 | RASORI HOSP | 16746 | 0% | 60% | 3 |
7 | CYTOL HISTOL EMBRYOL B | 13954 | 0% | 50% | 3 |
8 | SEZ FISIOL UMANA FUNZ BIOL INTEGRATE F BOTTAZZI | 13529 | 0% | 36% | 4 |
9 | MOL PHARMACOL NEUROSCI | 13151 | 1% | 8% | 17 |
10 | CLIN UNIT 3 | 12405 | 0% | 67% | 2 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY | 58518 | 3% | 6% | 113 |
2 | INTERNATIONAL JOURNAL OF IMMUNOTHERAPY | 38167 | 1% | 9% | 44 |
3 | THYMUS | 30871 | 1% | 8% | 44 |
4 | SURVEY OF IMMUNOLOGIC RESEARCH | 23960 | 1% | 12% | 21 |
5 | VITAMINS AND HORMONES | 6447 | 0% | 5% | 13 |
6 | CLINICS IN IMMUNOLOGY AND ALLERGY | 4579 | 0% | 5% | 9 |
7 | ANNALS OF THE NEW YORK ACADEMY OF SCIENCES | 4398 | 4% | 0% | 140 |
8 | JOURNAL OF BIOLOGICAL RESPONSE MODIFIERS | 4270 | 0% | 3% | 15 |
9 | IMMUNOPHARMACOLOGY | 3348 | 1% | 2% | 22 |
10 | IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY | 2581 | 1% | 1% | 22 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | THYMOSIN BETA 4 | 1445059 | 6% | 82% | 189 | Search THYMOSIN+BETA+4 | Search THYMOSIN+BETA+4 |
2 | THYMOSIN ALPHA 1 | 830623 | 4% | 74% | 121 | Search THYMOSIN+ALPHA+1 | Search THYMOSIN+ALPHA+1 |
3 | PROTHYMOSIN ALPHA | 787021 | 3% | 83% | 102 | Search PROTHYMOSIN+ALPHA | Search PROTHYMOSIN+ALPHA |
4 | THYMOSIN BETA4 | 449285 | 2% | 93% | 52 | Search THYMOSIN+BETA4 | Search THYMOSIN+BETA4 |
5 | THYMOSIN | 410307 | 2% | 70% | 63 | Search THYMOSIN | Search THYMOSIN |
6 | THYMULIN | 325109 | 2% | 56% | 62 | Search THYMULIN | Search THYMULIN |
7 | BETA THYMOSIN | 301108 | 1% | 83% | 39 | Search BETA+THYMOSIN | Search BETA+THYMOSIN |
8 | THYMOSIN BETA 10 | 232612 | 1% | 83% | 30 | Search THYMOSIN+BETA+10 | Search THYMOSIN+BETA+10 |
9 | BACTERIAL EXTRACT | 196556 | 1% | 81% | 26 | Search BACTERIAL+EXTRACT | Search BACTERIAL+EXTRACT |
10 | CAS 121808 62 6 | 169724 | 1% | 79% | 23 | Search CAS+121808+62+6 | Search CAS+121808+62+6 |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | SRIBENJA, S , WONGKHAM, S , WONGKHAM, C , YAO, QZ , CHEN, CY , (2013) ROLES AND MECHANISMS OF BETA-THYMOSINS IN CELL MIGRATION AND CANCER METASTASIS: AN UPDATE.CANCER INVESTIGATION. VOL. 31. ISSUE 2. P. 103-110 | 116 | 92% | 13 |
2 | HANNAPPEL, E , HUFF, T , (2003) THE THYMOSINS - PROTHYMOSIN ALPHA, PARATHYMOSIN, AND BETA-THYMOSINS: STRUCTURE AND FUNCTION.VITAMINS AND HORMONES - ADVANCES IN RESEARCH AND APPLICATIONS, VOL 66. VOL. 66. ISSUE . P. 257-296 | 158 | 83% | 60 |
3 | SAMARA, P , IOANNOU, K , TSITSILONIS, OE , (2016) PROTHYMOSIN ALPHA AND IMMUNE RESPONSES: ARE WE CLOSE TO POTENTIAL CLINICAL APPLICATIONS?.THYMOSINS. VOL. 102. ISSUE . P. 179 -207 | 98 | 90% | 0 |
4 | CHEN, CY , LI, M , YANG, H , CHAI, H , FISHER, W , YAO, QH , (2005) ROLES OF THYMOSINS IN CANCERS AND OTHER ORGAN SYSTEMS.WORLD JOURNAL OF SURGERY. VOL. 29. ISSUE 3. P. 264-270 | 111 | 93% | 32 |
5 | HUFF, T , MULLER, CSG , OTTO, AM , NETZKER, R , HANNAPPEL, E , (2001) BETA-THYMOSINS, SMALL ACIDIC PEPTIDES WITH MULTIPLE FUNCTIONS.INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY. VOL. 33. ISSUE 3. P. 205-220 | 101 | 84% | 272 |
6 | IOANNOU, K , SAMARA, P , LIVANIOU, E , DERHOVANESSIAN, E , TSITSILONIS, OE , (2012) PROTHYMOSIN ALPHA: A UBIQUITOUS POLYPEPTIDE WITH POTENTIAL USE IN CANCER DIAGNOSIS AND THERAPY.CANCER IMMUNOLOGY IMMUNOTHERAPY. VOL. 61. ISSUE 5. P. 599-614 | 88 | 85% | 14 |
7 | BEN-EFRAIM, S , KEISARI, Y , OPHIR, R , PECHT, M , TRAININ, N , BURSTEIN, Y , (1999) IMMUNOPOTENTIATING AND IMMUNOTHERAPEUTIC EFFECTS OF THYMIC HORMONES AND FACTORS WITH SPECIAL EMPHASIS ON THYMIC HUMORAL FACTOR THF-GAMMA 2.CRITICAL REVIEWS IN IMMUNOLOGY. VOL. 19. ISSUE 4. P. 261 -284 | 125 | 86% | 15 |
8 | PINEIRO, A , CORDERO, OJ , NOGUEIRA, M , (2000) FIFTEEN YEARS OF PROTHYMOSIN ALPHA: CONTRADICTORY PAST AND NEW HORIZONS.PEPTIDES. VOL. 21. ISSUE 9. P. 1433-1446 | 107 | 90% | 65 |
9 | GOLDSTEIN, AL , HANNAPPEL, E , SOSNE, G , KLEINMAN, HK , (2012) THYMOSIN BETA(4): A MULTI-FUNCTIONAL REGENERATIVE PEPTIDE. BASIC PROPERTIES AND CLINICAL APPLICATIONS.EXPERT OPINION ON BIOLOGICAL THERAPY. VOL. 12. ISSUE 1. P. 37 -51 | 68 | 79% | 38 |
10 | REGGIANI, PC , SCHWERDT, JI , CONSOLE, GM , ROGGERO, EA , DARDENNE, M , GOYA, RG , (2014) PHYSIOLOGY AND THERAPEUTIC POTENTIAL OF THE THYMIC PEPTIDE THYMULIN.CURRENT PHARMACEUTICAL DESIGN. VOL. 20. ISSUE 29. P. 4690 -4696 | 62 | 89% | 3 |
Classes with closest relation at Level 2 |